RISK
Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning
HEAD-TO-HEAD COMPARISON · 2026
PipFarm vs Monevis
Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.
PFAR
PipFarm
EST. 2023
MNVS
Monevis
EST. 2023
PIPFARM
METRIC
MONEVIS
72/100BETTER
TRUST SCORE
—68/100
0/5TIE
RATING
TIE0/5
85%TIE
PROFIT SPLIT
TIE85%
$200,000—
MAX FUNDING
BETTER$400,000
$45BETTER
MIN COST
—$49
7dTIE
PAYOUT DAYS
TIE7d
—
PASS RATE
—
0TIE
REVIEW COUNT
TIE0
PIPFARM DETAILS
- STEPS
- 1-phase
- DRAWDOWN
- Fixed
- MARKETS
- Forex, Indices, Commodities, Metals
- PLATFORMS
- MT4, MT5
- TYPES
- forex, fast-payout
MONEVIS DETAILS
- STEPS
- 2-phase
- DRAWDOWN
- Fixed
- MARKETS
- Forex, Indices, Commodities, Metals
- PLATFORMS
- MT4, MT5
- TYPES
- forex
PipFarm PROS
- +Minimum challenge cost of $45 is well below the industry average of $186.7.
- +Single-step funding process beats the industry average of 1.6 steps to funded.
- +Profit split of 85% slightly exceeds the industry average of 84.7%.
- +News trading, EA/automated trading, and weekend holding are all permitted.
PipFarm CONS
- −Max funding of $200,000 is significantly below the industry average of $839,272.7.
- −Days to first payout at 7 is slightly above the industry average of 6.5.
- −Founded in 2023, offering a limited operational track record for traders to assess.
Monevis PROS
- +Profit split of 85% is above the industry average of 84.7%, giving traders a slightly better earnings share.
- +Min challenge cost of $49 is well below the industry average of $186.7, making entry highly affordable.
- +Weekend holding, news trading, and EA/automated trading are all permitted, supporting diverse trading approaches.
- +On-demand payouts provide traders with maximum flexibility in withdrawing earned profits.
Monevis CONS
- −Max funding of $400,000 is well below the industry average of $839,272.7, limiting overall earning potential.
- −Overall drawdown of 8% slightly exceeds the industry average of 7.9%, offering marginally less buffer.
- −Founded in 2023, Monevis has a limited track record, which may concern traders prioritising firm stability.
PROPDNA VERDICT
RELATED LINKS
Affiliate disclosure: PropDNA may earn a commission if you start a challenge through links on this page. Scores are calculated algorithmically from verified trader reviews — not influenced by commercial relationships.Privacy Policy